What we do

The HUB builds a comprehensive Living Biobank of well-characterized organoids and develops assays for drug screening and validation: The Organoid Technology.  The HUB offers licenses to its patented Organoid Technology for in-house drug-screening and access to organoids in the Living Biobank for in-house preclinical drug discovery and validation. In addition, the HUB provides drug screening services to third parties. The platform provides an advanced translational medicine approach to validate candidate product leads, and guide the design of clinical trials based on patient stratification.

copyrights 2014 Hubrecht Organoid Technology